Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody-Reference-Cited by-同舟云学术

Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody

Published:2022-03 Issue: Volume:24 Page:719-728
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Ye Jing^ORCID,Jia Yujie,Tuhin Israth Jahan,Tan Jingwen,Monty Masuma Akter,Xu Nan,Kang Liqing,Li Minghao,Lou Xiaoyan,Zhou Meixia,Fang Xiaoyan,Shao Jiaqi,Zhu Hongjia,Yan Zhiqiang^ORCID,Yu Lei^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference40 articles.

1. Chimeric antigen receptors for T-cell malignancies;Scherer;Front. Oncol.,2019

2. The genetics and mechanisms of T cell acute lymphoblastic leukaemia;Belver;Nat. Rev. Cancer,2016

3. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL;Rodriguez;Leukemia,2020

4. T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies;Vadillo;Blood Rev.,2018

5. Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions;Fleischer;J. Hematol. Oncol.,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T-cells for T-cell acute lymphoblastic leukemia;EJC Paediatric Oncology;2024-06

2. Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation;Frontiers in Immunology;2024-04-30

3. Targeted gene delivery through receptors with lipid nanoparticles;Journal of Drug Delivery Science and Technology;2024-03

4. CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

5. Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies;Transplantation and Cellular Therapy;2024-02